These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24157866)

  • 21. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
    Zhang W; Zhang Y; Xi S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
    Ou H; Li Y; Kang M
    PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
    Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y; Li Q; Guo L
    Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis.
    Luo SD; Tsai HT; Hwang CF; Chiu TJ; Li SH; Hsu YL; Hsiao CC; Chen CH
    J Exp Clin Cancer Res; 2022 Jul; 41(1):215. PubMed ID: 35778755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
    Deng M; Ye Q; Qin Z; Zheng Y; He W; Tang H; Zhou Y; Xiong W; Zhou M; Li X; Yan Q; Ma J; Li G
    Tumour Biol; 2013 Jun; 34(3):1793-800. PubMed ID: 23479198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.
    Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
    Cancer Res; 2005 Dec; 65(24):11282-6. PubMed ID: 16357133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
    Zhang W; Zhang Q; Cui Q; Xu Y
    Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
    Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
    Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.
    Lyu X; Fang W; Cai L; Zheng H; Ye Y; Zhang L; Li J; Peng H; Cho WC; Wang E; Marincola FM; Yao K; Cai H; Li J; Li X
    Mol Cancer; 2014 Mar; 13():51. PubMed ID: 24606633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation.
    Shen L; Ling M; Li Y; Xu Y; Zhou Y; Ye J; Pang Y; Zhao Y; Jiang R; Zhang J; Liu Q
    PLoS One; 2013; 8(3):e57652. PubMed ID: 23469214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [No Abstract]   [Full Text] [Related]  

  • 34. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
    Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.
    Long Z; Wang B; Tao D; Huang Y; Tao Z
    Int J Mol Med; 2014 Nov; 34(5):1388-94. PubMed ID: 25231528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
    Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma.
    Zhang ZC; Li YY; Wang HY; Fu S; Wang XP; Zeng MS; Zeng YX; Shao JY
    PLoS One; 2014; 9(1):e86149. PubMed ID: 24465927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H
    Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.